The effects of idazoxan, a novel antidepressant that is a potent and selective α2-adrenoceptor antagonist, were studied on sleep. Twelve normal male volunteers had sleep recordings made using the Oxford ambulatory system (Medilog 9000) with subsequent analysis by automatic sleep staging and visual inspection. Idazoxan was given in a dose of 40 mg three times a day for 21 days. Sleep recording on day 3 demonstrated markedly reduced indices of rapid eye movement (REM) sleep, although other sleep parameters were only minimally affected. The effect on REM persisted unchanged at day 18, however on the second day after withdrawal a rebound in REM measures was observed. These data show that idazoxan has an effect on sleep which is very similar to that of other antidepressants, and emphasize a role for noradrenaline in the regulation of REM sleep.
Get full access to this article
View all access options for this article.
References
1.
Akindele M O, Evans J.I., Oswald I. (1970) Mono-amine oxidase inhibitors, sleep and mood . Electroenceph Clin Neurophysiol290: 47-56
2.
Berridge T.L., Gadie B., Roach A.G., Tulloch I.F. (1983) α2adrenoceptor agonists induce mydriasis in the rat by an action within the central nervous system. Br J Pharmacol78: 507-515
3.
Cedarbaum J.M., Aghajanian G.K. (1976) Noradrenergic neurons of the locus coeruleus: inhibition by epinephrine and activation by the alpha antagonist piperoxane . Brain Res112: 413-419
4.
Charney D.S., Redmond D.E. (1983) Neurobiological mechanisms in human anxiety. Neuropharmacology22: 1531-1536
5.
Checkley S.A., Slade A.P., Shur E. ( 1981) Growth hormone and other responses to clonidine in patients with endogenous depression. Br J Psychiat138: 51-55
6.
Davis D.M. (1988) Technical considerations when recording the sleep erection cycle (SEC)J Polysomnographic Technol Spring: 49-51
7.
Dennis T., L'Heureux R., Carter C., Scatton B. (1987) Presynaptic α2-adrenoceptors play a major role in the effects of idazoxan on cortical noradrenaline (as measured by in vivo dialysis) in the rat. J Pharmacol Exp Ther241: 642-649
8.
Dickinson S.L., Gadie B., Hunter C., Tulloch I.F. (1989) Behavioural effects of idazoxan given continuously by osmotic minipump in the rat. Br J Pharmacol98: 932p
9.
Doxey J.C., Roach A.G., Smith C F C (1983) Studies on RX781094. A selective and specific antagonist of α2adrenoceptors. Br J Pharmacol78: 489-505
10.
Dunleavy D L F, Brezinova V., Oswald I., Maclean A.W., Tinker M. (1972) Changes during week in effects of tricyclic drugs on the human sleeping brain, Br J Psychiat120:663-672
Glue P., Nutt D.J. (1989) Clonidine challenge testing of alpha-2-adrenoceptor function in man; the effects of mental illness and psychotropic medication . J Psychopharmacol2 : 119-137
13.
Hartmann E., Cravens J. (1973) The effects of long-term administration of psychotropic drugs on human sleep: II. The effects of reserpine. Psychopharmacologia (Berlin) 33: 169-174
14.
Kupfer D.J., Shipley J.A., Perel J.M., Pollock B., Coble P.A., Spiker D.G. (1987) Antidepressants and EEG sleep: search for specificity . In Dahl S G, Gram L F, Paul S M, Potter W Z (eds), Clinical pharmacology in psychiatry (Psychopharmacology Series 3). Springer-VerlagBerlin, Heidelberg, pp. 157-173
15.
Mendelson W.B., Gillin J.C., Wyatt R.J. (1977) Human sleep and its disorders. Plenum, New York
16.
Michel M.C., Insel P.A. (1989) Are there multiple imidazoline binding sites?Trends Pharmacol Sci10: 342-344
17.
Monti J.M. (1987) Disturbances of sleep and wakefulness associated with the use of antihypertensive agents. Life Sci41: 1979-1988
18.
Nicholson A.N., Pascoe P.A. (1990) Modulation of sleep in man with an α 2-adrenoceptor agonist (clonidine) and an antagonist (idazoxan). Br J Clin Pharmacol29: 138p-139p
19.
Osman O.T., Rudorfer M.V., Potter W.Z. (1989) Idazoxan: a selective α2-antagonist and effective sustained antidepressant in two bipolar depressed patients. Arch Gen Psych46: 958-959
20.
Oswald I., Thacore V.R., Adam K., Brezinova V., Burack R. (1975) α-Adrenergic receptor blockade increases human REM sleep. Br J Clin Pharmacol2: 107-110
21.
Rechtschaffen A., Kales A. (1968) A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. US Department of HEW, Washington
22.
Ruffolo R.R. ( 1988) Structure-activity relationships for alpha-2 adrenergic receptor agonists and antagonists. In Limbird L (ed.), The alpha-2 adrenergic receptors. Humana, Clifton, New Jersey , pp. 115-176
23.
Sharpley A.L., Solomon R.A., Cowen P.J. (1988) Evaluation of first night effect using ambulatory monitoring and automatic sleep stage analysis. Sleep11: 273-276
24.
Spiegel R., Devos J.E. (1980) Central effects of guanfacine and clonidine during wakefulness and sleep in healthy subjects. Br J Clin Pharmacol10: 165s-168s
25.
Thomas D.N., Holman R.B. (1991) A microdialysis study of the regulation of endogenous noradrenaline release in rat hippocampusJ Neurochem (in press)
26.
Walter W.S., Flockhart I.R., Haynes M.J., Howlett D.R., Lane A.C., Burton R., Johnson J., Dettmar P.W. (1984) Effects of idazoxan on catecholamine systems in rat brain. Biochem Pharmacol33: 2553-2557
